Connection

Evangelos Terpos to Proteasome Inhibitors

This is a "connection" page, showing publications Evangelos Terpos has written about Proteasome Inhibitors.
Connection Strength

0.230
  1. Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. J Cell Mol Med. 2019 12; 23(12):8010-8018.
    View in: PubMed
    Score: 0.188
  2. Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events. Sci Rep. 2017 12 19; 7(1):17802.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.